BDB563663
CD134 Mouse anti-Human, PE-Cy7, Clone: ACT35 (also known as Ber-ACT35), BD
Manufacturer: BD Biosciences
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | BDB563663-Each-of-1 | In Stock | ₹ 19,936.00 |
BDB563663 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 19,936.00
GST (18%): ₹ 3,588.48
Total Price: ₹ 23,524.48
Antigen
CD134
Classification
Monoclonal
Conjugate
PE-Cyanine7
Host Species
Mouse
Purification Method
Affinity Purified
Regulatory Status
RUO
Target Species
Human
Isotype
IgG1 κ
Applications
Flow Cytometry
Clone
ACT35 (also known as Ber-ACT35)
Description
OX40; TNFRSF4; TXGP1L; OX40L Receptor
Immunogen
Human HUT 102
Quantity
50 Tests
Primary or Secondary
Primary
Content And Storage
Store undiluted at 4°C and protected from prolonged exposure to light. Do not freeze.
Related Products
Description
- The ACT35 monoclonal antibody specifically binds to CD134 which is also known as OX40
- The 35 kDa CD134 polypeptide is encoded by the TNFRSF4 gene
- CD134 is a type I integral membrane glycoprotein and member of the tumor necrosis factor/nerve growth factor receptor (TNFR/NGFR) family
- CD134 is expressed on activated T lymphocytes, hematopoietic precursor cells and fibroblasts
- CD134 functions as a T cell costimulatory receptor when bound by OX40 Ligand/TNFSF4 that is expressed by antigen presenting cells
- CD134 thereby plays roles in T-cell activation as well as the regulation of differentiation, proliferation or apoptosis of normal and malignant lymphoid cells
- Analysis of the nucleotide sequence of the human TNFRSF4 cDNA reveals strong homology with the rat Tnfrsf4 cDNA sequence
- OX40 was clustered as CD134 in the Sixth International Workshop on Human Leukocyte Differentiation Antigens.